Genfit SA Appoints Pejvack Motlagh as Chief Medical Officer
Genfit SA has appointed Dr. Pejvack Motlagh as Chief Medical Officer to lead clinical development and oversee key teams. He has over 20 years of industry experience, previously serving as CMO at Egle Therapeutics and Mablink Biosciences. The announcement was made via GlobeNewswire on November 27, 2025.
Genfit SA has appointed Dr. Pejvack Motlagh as its new Chief Medical Officer. Dr. Motlagh will lead the clinical development strategy and oversee the Clinical, Biometrics, and Pharmacovigilance teams. He brings over 20 years of experience in the pharmaceutical and biotechnology industry, previously serving as CMO at Egle Therapeutics and Mablink Biosciences. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfit SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001141301-en) on November 27, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
